296th Edition – March 20, 2018

This discussion covers how David arrived in Maryland, the role of MCEDC in the BioHealth Capital Region, and why Montgomery County is a great place to do business.

Before becoming the inaugural President and CEO of MCEDC, David was with the Central Florida Development Council, where as President and CEO, he achieved record-setting job creation and capital investment results. Previously, David was the Executive Director of the Winter Haven Economic Development Council in Florida. In Texas, he has held key marketing management positions in economic development and was an advertising agency owner in Austin.

Listen now on iTunes , Google Play , and TuneIn. 

Read More

The FDA’s drive to accelerate access to new medical device technologies continues, with a new product from 3i Diagnostics receiving a Breakthrough Device Designation.

Read More

ExeGi Pharma LLC, a company focused on developing and commercializing live biotherapeutics and probiotic treatments, announced today that it has launched Visbiome® Vet, a new high potency probiotic for use in dogs to help support normal inflammatory responses in the gastrointestinal (GI) tract and to help normalize gut health.

Read More

You thought the Shark Tank was tough…

wait until you enter the the BioHealth Capital Region Crab Trap!

Submit your application for the opportunity to be named the company with the most commercial potential at the 2018 BioHealth Regional Forum, $10,000, and MORE!

Application Deadline: March, 30th 2018 

Finalists will be announced: April 9th, 2018 

Finalist Presentations BioHealth Capital Region Forum Event: April 24th, 2018

Submit an Application »

Read More

Novavax CEO Stanley Erck said he believes the last quarter was “the most significant in Novavax corporate history.”

The reason? Vaccines, specifically clinical results from the Gaithersburg company’s two lead vaccine programs: RSV for infants via maternal immunization and NanoFlu for seasonal flu.

Read More

Jarrod Borkat of MedImmune says what would help MedImmune would be other large biotech companies located in Montgomery County. Although he expects his company would lose talent, it would be a net gain.

Read More

Baltimore medical device firm Perceptive Navigation LLC is looking to raise $4 million in new funding, according to a recent filing with the U.S. Securities and Exchange Commission.

Read More

April 23-24  |  1 MedImmune Way, Gaithersburg MD 20878 

This invitation-only event is free for executive level biotech leaders and is presented by BioHealth Innovation, VirginiaBio, Inova, Children’s National Health System, QIAGEN, Maryland Tech Council, University System of Maryland and MedImmune/AstraZeneca. Maryland, Virginia, and Washington, DC set the bar high for biotech innovation. So please join us for our Annual BioHealth Capital Region Forum that will highlight the accomplishments of today and chart our successes of tomorrow.

We are excited to bring you an exceptional line up of speakers. The program will feature sessions that focus on the Advancing Science and Accelerating Innovation.

Read More

Freeman Hrabowski III, the university president and most notable dreamer at Maryland Baltimore County, didn’t close his eyes until 6 a.m. Saturday. He had too many text messages to answer, too many calls to take, too many voice mails to retrieve. He had too many people to hug, too many whys and hows to try to explain, too many Friday night thrills to relive.

Read More

At halftime, with players locked in a surprising tie with the top-ranked men’s basketball team in the country, the Twitter feed of the University of Maryland-Baltimore County’s athletic department seized the spotlight to make a sales pitch.

Read More

The University of Maryland, Baltimore County woke up on Friday as just another small basketball program looking forward to a run against a No. 1 seed in the NCAA tournament.

Read More

Platforms such as Amazon Publishing, Etsy and Instagram have yielded an entire new market of online artists and creators.

Read More

Roche is buying out the rest of Flatiron Health for $1.9 billion, the companies said Thursday. The total investment for Roche, a drug maker based in Switzerland, is about $2.1 billion in cash since it already owned about 13% of Flatiron, a tech company that handles electronic health records and data mining specifically for cancer doctors, researchers and patients.

Read More

Pharma major Lupin announced the launch of its Tydemy™ Tablets (Drospirenone, Ethinyl Estradiol, Levomefolate Calcium, 3mg/0.03mg/0.451mg and Levomefolate Calcium, 0.451mg) having received an approval from the United States Food and Drug Administration (FDA) earlier.

Read More

The Maryland Tech Council and SoBran are celebrating the transformational science coming out of Maryland and surrounding area by establishing the Innovation for Impact Prize. This is an added annual award at the Industry Awards Celebration. Tell us how your innovative research will impact the world one day and describe your research! Deadline to apply is April 17, 2018.

Read More

Healthwise and GetWellNetwork® announced today they will partner in offering health education to health care providers and their patients. GetWellNetwork will add over 600 Healthwise patient education videos to its current suite of patient experience technologies that deliver Precision Engagement™ across the care continuum.

Read More

ETC (The Emerging Technology Centers), Baltimore City’s technology and innovation center and award-winning entrepreneur support organization, was ranked seventh, globally, in UBI’S World Incubator Summit Awards for World of Top Business Incubator – Collaborating with University.

Read More

Emerging Technology Centers announced the seven companies that have been accepted into its 2018 Accelerate Baltimore cohort.

Read More

Scheer Partners, the leading provider of fully integrated commercial real estate services in the Washington and Baltimore metropolitan areas, announced today that it has negotiated on behalf of Supernus Pharmaceuticals, Inc., a 118,000-square-foot headquarters lease at 700 Quince Orchard Road, a building owned by the Rock Creek Fund.

Read More

Proscia Inc., creators of AI-powered digital pathology software, today announced it has signed a first-of-its-kind agreement with one of the largest dermatopathology labs in the country, signaling Proscia’s entrance into the dermatopathology market and ushering in a new era of digital and computational pathology applied to dermatology.

Read More

The year 2017 marked yet another exciting period of innovation and growth for the University of Maryland (UMD) research community, with over 170 inventions disclosed and 52 patented, 46 technologies licensed, and the receipt of the largest investment in UMD history in total of $219.5 million from the A. James and Alice B. Clark Foundation. Researchers broke barriers in fields related to agriculture, information management, biotechnology, and energy, making discoveries and inventing technologies that have the potential to make positive impacts on the planet and on people’s lives around the globe.

Read More

Mosquitoes are bad news when it comes to the spread of malaria, a deadly disease which kills hundreds of thousands of people each year. We previously covered a range of approaches to cracking down on this problem — ranging from apps which track disease-carrying mosquitoes by listening to their buzz to a plan to release genetically engineered killer mosquitoes to hunt down their disease-carrying wild counterparts.

Read More

Village Capital, a venture capital firm, and Kaiser Permanente have teamed up to address the needs of the aging population in America through a new program called Health: US 2018.

Read More

As we celebrate more women becoming medtech leaders and paving the way for innovation, it’s important to remember the many accomplishments women have already made when it comes to the advancement of health and medicine.

Read More

Mid Atlantic Bio Angels (MABA) announces today the initiation of a second closed-end investment pool (Pool II) funded by current, active MABA members, and the inaugural investment from that pool made into Israel-based POP Medical Solutions Ltd., which focuses on the treatment of pelvic organ prolapse (POP).

Read More

Wed, Apr 11, 2018 2:00 PM – 3:30 PM EDT

USDA ARS and the USDA SBIR program formed a partnership to encourage USDA SBIR applicants to develop research collaborations with ARS scientists and/or to license ARS technologies. The purpose is to increase the likelihood of success by providing both money and technologies to small U.S. businesses. The relevant language in the SBIR’s “Request for Application” states: “Additional factors that will be considered in the review process include whether an application involves a Cooperative Research and Development Agreement (CRADA) with a USDA laboratory, or a license to a USDA technology, or is a resubmission.”

Read More

Older people need more medicine. That rule of life is no secret to pharmaceutical companies across the globe. Many also realize that Japan’s rapidly aging population presents a unique business opportunity. Japan remains the world’s second-biggest pharmaceuticals market, behind only the United States and China. The Japanese market also is expected to grow annually. The lessons learned there will be critical as the population grows older in many other markets.

Read More

The Maryland Department of Assessments and Taxation unveiled a new website Monday designed to help small business owners and entrepreneurs plan, start, manage and grow their businesses.

Read More